Cogent Biosciences Inc. (COGT)
NASDAQ: COGT
· Real-Time Price · USD
7.46
0.38 (5.37%)
At close: Jun 16, 2025, 3:59 PM
7.12
-4.49%
After-hours: Jun 16, 2025, 07:55 PM EDT
5.37% (1D)
| Bid | 7.12 |
| Market Cap | 848.8M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -269.5M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -3.78 |
| Forward PE | -3.77 |
| Analyst | Buy |
| Ask | 7.55 |
| Volume | 1,486,012 |
| Avg. Volume (20D) | 1,515,790 |
| Open | 7.24 |
| Previous Close | 7.08 |
| Day's Range | 6.96 - 7.47 |
| 52-Week Range | 3.72 - 12.61 |
| Beta | 0.23 |
About COGT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COGT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COGT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+12.91%
Cogent Biosciences shares are trading higher after...
Unlock content with
Pro Subscription
7 months ago
-15.84%
Cogent Biosciences shares are trading lower after the company announced Bezuclantinib presentations at the 66th annual American Society of Hematology meeting.
